[시장보고서]세계의 원격 환자 모니터링 시스템 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 용도별, 지역별, 부문별 예측(2025-2033년)

세계의 원격 환자 모니터링 시스템 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 용도별, 지역별, 부문별 예측(2025-2033년)

Remote Patient Monitoring System Market Size, Share & Trends Analysis Report By Product, By End Use, By Application, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1790204

리서치사 : Grand View Research

발행일 : 2025년 07월

페이지 정보 : 영문 120 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,572,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,013,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,895,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

원격 환자 모니터링 시스템 시장 개요

세계 원격 환자 모니터링 시스템 시장 규모는 2024년에 220억 3,000만 달러로 평가되었습니다. 2033년에는 1,107억 1,000만 달러에 달하고, 2025-2033년 19.8%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 원격 모니터링 시스템은 조기 경고 신호 및 경과 추적을 포함한 만성 질환 관리를 개선하는 데 도움이 되기 때문에 향후 몇 년 동안 전 세계적으로 수요가 증가할 것으로 예측됩니다.

원격 모니터링 시스템은 조기 경고 신호 및 경과 추적을 포함한 만성 질환 관리를 개선하는 데 도움이 되며, 향후 몇 년 동안 전 세계적으로 수요가 증가할 것으로 예측됩니다. 코로나19 사태로 인해 병원 공간이 부족해졌습니다. 이와는 별도로, 특히 만성질환을 앓고 있는 환자들은 감염의 위험이 있으므로 병원 방문을 피하는 것이 좋다고 권고했습니다. 이는 원격 환자 모니터링 시장 개척으로 이어졌습니다.

기업들은 새로운 스타트업과의 협력, 인수, 제휴를 통해 많은 투자를 하고 있습니다. 개인화된 원격의료 앱은 간병인과 환자의 가교역할을 하는 환자의 원격 실시간 모니터링을 위한 커뮤니케이션 플랫폼입니다. 필요에서 비롯된 이 한 단계 진전된 변화는 코로나19 이후 원격 환자 모니터링 시장 전체의 양상을 바꾸어 놓았습니다. 이러한 변화로 인해 소비자들이 앱에 적극적으로 참여하게 되었고, 회복 속도도 빨라졌습니다. 또한, 의료 제공업체의 앱 사용 의욕이 높아져 더 큰 접근성과 보상을 받을 수 있게 되었습니다.

시장 계통 전망
- 상위 시장 전망
- 보조 시장 전망
가격 모델 분석
- 구독 기반 가격 결정(연액 또는 월액)
- 사용량 기반 또는 인터랙션별 결제
- 수량 기준 할인 모델
- 번들 가격 모델
시장 역학
- 시장 성장 촉진요인 분석
- 시장 성장 억제요인 분석
수술 기구 추적 시스템 : 시장 분석 툴
- 산업 분석 - Porter의 Five Forces 분석
- PESTLE 분석
규제 상황
기술 개요
이용 사례 분석

제4장 원격 환자 모니터링 시스템 시장 부문 분석, 제품별, 2021-2033년

정의와 범위
제품 시장 점유율 분석, 2024년 & 2033년
부문 대시보드
세계의 원격 환자 모니터링 시스템 시장(제품별, 2021-2033년)
- 바이탈 사인 모니터
특별 모니터
- 시장 매출 추정과 예측, 2021-2033년

제5장 원격 환자 모니터링 시스템 시장 부문 분석, 용도별, 2021-2033년

정의와 범위
용도 시장 점유율 분석, 2024년 & 2033년
부문 대시보드
세계의 원격 환자 모니터링 시스템 시장(용도별, 2021-2033년)
암
- 시장 매출 추정과 예측, 2021-2033년
심혈관 질환
- 시장 매출 추정과 예측, 2021-2033년
당뇨병
- 시장 매출 추정과 예측, 2021-2033년
수면장애
- 시장 매출 추정과 예측, 2021-2033년
체중 관리 및 피트니스 모니터링
- 시장 매출 추정과 예측, 2021-2033년
기관지염
- 시장 매출 추정과 예측, 2021-2033년
감염증
- 시장 매출 추정과 예측, 2021-2033년
바이러스
- 시장 매출 추정과 예측, 2021-2033년
탈수
- 시장 매출 추정과 예측, 2021-2033년
고혈압
- 시장 매출 추정과 예측, 2021-2033년

제6장 원격 환자 모니터링 시스템 시장 부문 분석, 최종 용도별, 2021-2033년

정의와 범위
최종 용도 시장 점유율 분석, 2024년 & 2033년
부문 대시보드
세계의 원격 환자 모니터링 시스템 시장(최종 용도별, 2021-2033년)
입원 환자
- 시장 매출 추정과 예측, 2021-2033년
외래 환자
- 시장 매출 추정과 예측, 2021-2033년
재택 헬스케어
- 시장 매출 추정과 예측, 2021-2033년

제7장 원격 환자 모니터링 시스템 시장 부문 분석, 지역별, 2021-2033년

지역별 시장 점유율 분석, 2024년 & 2033년
지역별 시장 대시보드
지역 시장 스냅숏
원격 환자 모니터링 시스템 시장 점유율(지역별, 2024년 & 2033년)
북미
- 북미의 원격 환자 모니터링 시스템 시장, 2021-2030년
- 미국
- 캐나다
- 멕시코
유럽
- 유럽의 원격 환자 모니터링 시스템 시장, 2021-2033년
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제8장 경쟁 구도

주요 시장 진출기업의 최근 동향과 영향 분석
기업 분류
기업의 시장 점유율 분석, 2024년(%)
기업 개요
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd
- Nihon Kohden Corporation
- Omron Corporation
- OSI Systems, Inc.
- Koninklijke Philips NV
- F. Hoffmann-La Roche Ltd
- Welch Allyn
- Smiths Medical
- Abbott
- Informatica Boston Scientific Corporation
- Drager Medical
- GE Healthcare
- Honeywell
- Johnson & Johnson
- LifeWatch
- Medtronic
- Masimo
- Vitls, Inc
- CareValidate
- BIoTronik
- American Telecare

LSH

영문 목차

영문목차

Remote Patient Monitoring System Market Summary

The global remote patient monitoring system market size was estimated at USD 22.03 billion in 2024 and is projected to reach USD 110.71 billion by 2033, growing at a CAGR of 19.8% from 2025 to 2033. The remote monitoring systems serve with improved chronic disease management including early warning signs and progress tracker thus boosting its demand in the coming years at a global level.

The remote monitoring systems serve with improved chronic disease management including early warning signs and progress tracker thus boosting its demand in the coming years at a global level. The COVID-19 pandemic led to a shortage of space in hospitals. Apart from this, patients, especially those suffering from chronic diseases, were advised to avoid physical visits to hospitals owing to the threat of getting infected. This led to the development of remote patient monitoring market.

Firms make a large number of investments by collaborating, acquiring, and partnering with new emerging startups. The personalized telemedicine app provides a communication platform for remote and real-time monitoring of patients that acts as a bridge between caregiver and patient. This step-change, borne out of necessity, changed the entire look of the remote patient monitoring market post-COVID-19. This change has sped up recovery rates as consumers are more willing to join the app. It has also increased the provider's willingness to use the app, and it offers greater access and reimbursements.

Global Remote Patient Monitoring System Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global remote patient monitoring systems market report based on product, application, end use and region.

Product Outlook (Revenue, USD Million, 2021 - 2033)
Vital Sign Monitors
- Blood Pressure Monitors
- Pulse Oximeters
- Heart Rate Monitor (ECG)
- Temperature Monitor
- Respiratory Rate Monitor
- Brain Monitoring (EEG)
Special Monitors
- Anesthesia Monitors
- Blood Glucose Monitors
- Cardiac Rhythm Monitor
- Respiratory Monitor
- Fetal Heart Monitors
- Prothrombin Monitors
- Multi Parameter Monitors (MPM)
- Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Cancer
Cardiovascular Diseases
Diabetes
Sleep Disorder
Weight management and Fitness Monitoring
Bronchitis
Infections
Virus
Dehydration
Hypertension
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals Based Patients
Ambulatory Patients
Home Healthcare
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
  - 1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. End use outlook
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Remote Patient Monitoring Systems Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Ancillary market outlook
3.2. Pricing Model Analysis
- 3.2.1. Subscription-Based Pricing (Annual or Monthly)
- 3.2.2. Usage-Based or Pay-Per-Interaction
- 3.2.3. Volume-Based Discount Model
- 3.2.4. Bundled Pricing Model
3.3. Market Dynamics
- 3.3.1. Market driver analysis
  - 3.3.1.1. Increasing Prevalence of Chronic Diseases
  - 3.3.1.2. Rising adoption of telehealth and digital health platforms
  - 3.3.1.3. Technological advancements in wearable and connected devices
- 3.3.2. Market restraint analysis
  - 3.3.2.1. Data Security and Privacy Concerns
  - 3.3.2.2. Limited reimbursement policies and regulatory variability across regions
3.4. Surgical Instrument Tracking Systems: Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
  - 3.4.1.1. Supplier power
  - 3.4.1.2. Buyer power
  - 3.4.1.3. Substitution threat
  - 3.4.1.4. Threat of new entrant
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTLE Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic landscape
  - 3.4.2.3. Social landscape
  - 3.4.2.4. Technological landscape
  - 3.4.2.5. Environmental landscape
  - 3.4.2.6. Legal landscape
3.5. Regulatory Landscape
3.6. Technology Overview
3.7. Case Study Analysis

Chapter 4. Remote Patient Monitoring Systems Market Segment Analysis, By Product Type, 2021 - 2033 (USD Million)

4.1. Definition and Scope
4.2. Product Market Share Analysis, 2024 & 2033
4.3. Segment Dashboard
4.4. Global Remote Patient Monitoring Systems Market, by Product, 2021 to 2033
- 4.4.1. Vital Sign Monitors
  - 4.4.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.1.2. Blood Pressure Monitors
    - 4.4.1.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.1.3. Pulse Oximeters
    - 4.4.1.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.1.4. Heart Rate Monitor
    - 4.4.1.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.1.5. Temperature Monitors
    - 4.4.1.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.1.6. Respiratory Rate Monitors
    - 4.4.1.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      - 4.4.1.6.1.1. Canographs
        
        4.4.1.6.1.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      - 4.4.1.6.1.2. Spirometers
        
        4.4.1.6.1.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.1.7. Brain Monitoring (EEG)
    - 4.4.1.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Special Monitors
- 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.5.1.1. Anesthesia Monitor
    - 4.5.1.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.5.1.2. Blood Glucose Monitor
    - 4.5.1.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.5.1.3. Cardiac Rhythm Monitor
    - 4.5.1.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.5.1.4. Respiratory Monitor
    - 4.5.1.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.5.1.5. Fetal Heart Monitor
    - 4.5.1.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.5.1.6. Prothrombin Monitor
    - 4.5.1.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.5.1.7. Multi Parameter Monitor
    - 4.5.1.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.5.1.8. Others Monitor
    - 4.5.1.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Remote Patient Monitoring Systems Market Segment Analysis, By Application, 2021 - 2033 (USD Million)

5.1. Definition and Scope
5.2. Application Market Share Analysis, 2024 & 2033
5.3. Segment Dashboard
5.4. Global Remote Patient Monitoring Systems Market, by Application, 2021 to 2033
5.5. Cancer
- 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Cardiovascular Diseases
- 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Diabetes
- 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Sleep Disorder
- 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.9. Weight Management and Fitness Monitoring
- 5.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.10. Bronchitis
- 5.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.11. Infections
- 5.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 5.11.1.1. Eye infections
    - 5.11.1.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 5.11.1.2. Sinus Infections
    - 5.11.1.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 5.11.1.3. Strep Throat
    - 5.11.1.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.12. Virus
- 5.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.13. Dehydration
- 5.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.14. Hypertension
- 5.14.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Remote Patient Monitoring Systems Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

6.1. Definition and Scope
6.2. End use Market Share Analysis, 2024 & 2033
6.3. Segment Dashboard
6.4. Global Remote Patient Monitoring Systems Market, by End Use, 2021 to 2033
6.5. Hospital-based patients
- 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Ambulatory patients
- 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Home Healthcare
- 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Remote Patient Monitoring Systems Market Segment Analysis, By Region, 2021- 2033 (USD Million)

7.1. Regional Market Share Analysis, 2024 & 2033
7.2. Regional Market Dashboard
7.3. Regional Market Snapshot
7.4. Remote Patient Monitoring Systems Market Share by Region, 2024 & 2033:
7.5. North America
- 7.5.1. North America remote patient monitoring systems market, 2021 - 2030 (USD Million)
- 7.5.2. U.S.
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Regulatory Scenario
  - 7.5.2.3. Competitive Scenario
  - 7.5.2.4. U.S. remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.5.3. Canada
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Regulatory Scenario
  - 7.5.3.3. Competitive Scenario
  - 7.5.3.4. Canada remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.5.4. Mexico
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Regulatory Scenario
  - 7.5.4.3. Competitive Scenario
  - 7.5.4.4. Mexico remote patient monitoring systems market, 2021 - 2033 (USD Million)
7.6. Europe
- 7.6.1. Europe remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.6.2. UK
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Regulatory Scenario
  - 7.6.2.3. Competitive Scenario
  - 7.6.2.4. UK remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.6.3. Germany
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Regulatory Scenario
  - 7.6.3.3. Competitive Scenario
  - 7.6.3.4. Germany remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.6.4. France
  - 7.6.4.1. Key Country Dynamics
  - 7.6.4.2. Regulatory Scenario
  - 7.6.4.3. Competitive Scenario
  - 7.6.4.4. France remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.6.5. Italy
  - 7.6.5.1. Key Country Dynamics
  - 7.6.5.2. Regulatory Scenario
  - 7.6.5.3. Competitive Scenario
  - 7.6.5.4. Italy remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.6.6. Spain
  - 7.6.6.1. Key Country Dynamics
  - 7.6.6.2. Regulatory Scenario
  - 7.6.6.3. Competitive Scenario
  - 7.6.6.4. Spain remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.6.7. Norway
  - 7.6.7.1. Key Country Dynamics
  - 7.6.7.2. Regulatory Scenario
  - 7.6.7.3. Competitive Scenario
  - 7.6.7.4. Norway remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.6.8. Sweden
  - 7.6.8.1. Key Country Dynamics
  - 7.6.8.2. Regulatory Scenario
  - 7.6.8.3. Competitive Scenario
  - 7.6.8.4. Sweden remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.6.9. Denmark
  - 7.6.9.1. Key Country Dynamics
  - 7.6.9.2. Regulatory Scenario
  - 7.6.9.3. Competitive Scenario
  - 7.6.9.4. Denmark remote patient monitoring systems market, 2021 - 2033 (USD Million)
7.7. Asia Pacific
- 7.7.1. Japan
  - 7.7.1.1. Key Country Dynamics
  - 7.7.1.2. Regulatory Scenario
  - 7.7.1.3. Competitive Scenario
  - 7.7.1.4. Japan remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.7.2. China
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Regulatory Scenario
  - 7.7.2.3. Competitive Scenario
  - 7.7.2.4. China remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.7.3. India
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Regulatory Scenario
  - 7.7.3.3. Competitive Scenario
  - 7.7.3.4. India remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.7.4. Australia
  - 7.7.4.1. Key Country Dynamics
  - 7.7.4.2. Regulatory Scenario
  - 7.7.4.3. Competitive Scenario
  - 7.7.4.4. Australia remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.7.5. South Korea
  - 7.7.5.1. Key Country Dynamics
  - 7.7.5.2. Regulatory Scenario
  - 7.7.5.3. Competitive Scenario
  - 7.7.5.4. South Korea remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.7.6. Thailand
  - 7.7.6.1. Key Country Dynamics
  - 7.7.6.2. Regulatory Scenario
  - 7.7.6.3. Competitive Scenario
  - 7.7.6.4. Thailand remote patient monitoring systems market, 2021 - 2033 (USD Million)
7.8. Latin America
- 7.8.1. Brazil
  - 7.8.1.1. Key Country Dynamics
  - 7.8.1.2. Regulatory Scenario
  - 7.8.1.3. Competitive Scenario
  - 7.8.1.4. Brazil remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.8.2. Argentina
  - 7.8.2.1. Key Country Dynamics
  - 7.8.2.2. Regulatory Scenario
  - 7.8.2.3. Competitive Scenario
  - 7.8.2.4. Argentina remote patient monitoring systems market, 2021 - 2033 (USD Million)
7.9. MEA
- 7.9.1. South Africa
  - 7.9.1.1. Key Country Dynamics
  - 7.9.1.2. Regulatory Scenario
  - 7.9.1.3. Competitive Scenario
  - 7.9.1.4. South Africa remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.9.2. Saudi Arabia
  - 7.9.2.1. Key Country Dynamics
  - 7.9.2.2. Regulatory Scenario
  - 7.9.2.3. Competitive Scenario
  - 7.9.2.4. Saudi Arabia remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.9.3. UAE
  - 7.9.3.1. Key Country Dynamics
  - 7.9.3.2. Regulatory Scenario
  - 7.9.3.3. Competitive Scenario
  - 7.9.3.4. UAE remote patient monitoring systems market, 2021 - 2033 (USD Million)
- 7.9.4. Kuwait
  - 7.9.4.1. Key Country Dynamics
  - 7.9.4.2. Regulatory Scenario
  - 7.9.4.3. Competitive Scenario
  - 7.9.4.4. Kuwait remote patient monitoring systems market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company Categorization
8.3. Company Market Share Analysis, 2024 (%)
8.4. Company Profiles
- 8.4.1. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  - 8.4.1.1. Company overview
  - 8.4.1.2. Financial performance
  - 8.4.1.3. Solution Type benchmarking
  - 8.4.1.4. Strategic initiatives
- 8.4.2. Nihon Kohden Corporation
  - 8.4.2.1. Company overview
  - 8.4.2.2. Financial performance
  - 8.4.2.3. Solution Type benchmarking
  - 8.4.2.4. Strategic initiatives
- 8.4.3. Omron Corporation
  - 8.4.3.1. Company overview
  - 8.4.3.2. Financial performance
  - 8.4.3.3. Solution Type benchmarking
  - 8.4.3.4. Strategic initiatives
- 8.4.4. OSI Systems, Inc.
  - 8.4.4.1. Company overview
  - 8.4.4.2. Financial performance
  - 8.4.4.3. Solution Type benchmarking
  - 8.4.4.4. Strategic initiatives
- 8.4.5. Koninklijke Philips N.V.
  - 8.4.5.1. Company overview
  - 8.4.5.2. Financial performance
  - 8.4.5.3. Solution Type benchmarking
  - 8.4.5.4. Strategic initiatives
- 8.4.6. F. Hoffmann-La Roche Ltd
  - 8.4.6.1. Company overview
  - 8.4.6.2. Financial performance
  - 8.4.6.3. Solution Type benchmarking
  - 8.4.6.4. Strategic initiatives
- 8.4.7. Welch Allyn
  - 8.4.7.1. Company overview
  - 8.4.7.2. Financial performance
  - 8.4.7.3. Solution Type benchmarking
  - 8.4.7.4. Strategic initiatives
- 8.4.8. Smiths Medical
  - 8.4.8.1. Company overview
  - 8.4.8.2. Financial performance
  - 8.4.8.3. Solution Type benchmarking
  - 8.4.8.4. Strategic initiatives
- 8.4.9. Abbott
  - 8.4.9.1. Company overview
  - 8.4.9.2. Financial performance
  - 8.4.9.3. Solution Type benchmarking
  - 8.4.9.4. Strategic initiatives
- 8.4.10. Informatica Boston Scientific Corporation
  - 8.4.10.1. Company overview
  - 8.4.10.2. Financial performance
  - 8.4.10.3. Solution Type benchmarking
  - 8.4.10.4. Strategic initiatives
- 8.4.11. Drager Medical
  - 8.4.11.1. Company overview
  - 8.4.11.2. Financial performance
  - 8.4.11.3. Solution Type benchmarking
  - 8.4.11.4. Strategic initiatives
- 8.4.12. GE Healthcare
  - 8.4.12.1. Company overview
  - 8.4.12.2. Financial performance
  - 8.4.12.3. Solution Type benchmarking
  - 8.4.12.4. Strategic initiatives
- 8.4.13. Honeywell
  - 8.4.13.1. Company overview
  - 8.4.13.2. Financial performance
  - 8.4.13.3. Solution Type benchmarking
  - 8.4.13.4. Strategic initiatives
- 8.4.14. Johnson & Johnson
  - 8.4.14.1. Company overview
  - 8.4.14.2. Financial performance
  - 8.4.14.3. Solution Type benchmarking
  - 8.4.14.4. Strategic initiatives
- 8.4.15. LifeWatch
  - 8.4.15.1. Company overview
  - 8.4.15.2. Financial performance
  - 8.4.15.3. Solution Type benchmarking
  - 8.4.15.4. Strategic initiatives
- 8.4.16. Medtronic
  - 8.4.16.1. Company overview
  - 8.4.16.2. Financial performance
  - 8.4.16.3. Solution Type benchmarking
  - 8.4.16.4. Strategic initiatives
- 8.4.17. Masimo
  - 8.4.17.1. Company overview
  - 8.4.17.2. Financial performance
  - 8.4.17.3. Solution Type benchmarking
  - 8.4.17.4. Strategic initiatives
- 8.4.18. Vitls, Inc
  - 8.4.18.1. Company overview
  - 8.4.18.2. Financial performance
  - 8.4.18.3. Solution Type benchmarking
  - 8.4.18.4. Strategic initiatives
- 8.4.19. CareValidate
  - 8.4.19.1. Company overview
  - 8.4.19.2. Financial performance
  - 8.4.19.3. Solution Type benchmarking
  - 8.4.19.4. Strategic initiatives
- 8.4.20. Biotronik
  - 8.4.20.1. Company overview
  - 8.4.20.2. Financial performance
  - 8.4.20.3. Solution Type benchmarking
  - 8.4.20.4. Strategic initiatives
- 8.4.21. American Telecare
  - 8.4.21.1. Company overview
  - 8.4.21.2. Financial performance
  - 8.4.21.3. Solution Type benchmarking
  - 8.4.21.4. Strategic initiatives